Literature DB >> 1298068

Drug resistant malaria, with special reference to Thailand.

S Looareesuwan1, T Harinasuta, T Chongsuphajaisiddhi.   

Abstract

Drug resistance of malaria parasites is a major problem confronting efforts to treat and control malaria. Starting with chloroquine, the emergence of resistance to other drugs has led to multi-drug resistance patterns that pose increasing threats for the future. This report reviews work carried out over the past decades at the Hospital for Tropical Diseases, Bangkok, which monitors patients from many areas, including the Thai-Cambodian border, which harbors the world's most severe multi-drug resistant Plasmodium falciparum.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1298068

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  13 in total

1.  Variations in frequencies of drug resistance in Plasmodium falciparum.

Authors:  P K Rathod; T McErlean; P C Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

Review 2.  Chloroquine resistance in Plasmodium vivax.

Authors:  J Kevin Baird
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

3.  Population pharmacokinetics and therapeutic response of CGP 56697 (artemether + benflumetol) in malaria patients.

Authors:  F Ezzet; R Mull; J Karbwang
Journal:  Br J Clin Pharmacol       Date:  1998-12       Impact factor: 4.335

4.  New fixed-dose artesunate-mefloquine formulation against multidrug-resistant Plasmodium falciparum in adults: a comparative phase IIb safety and pharmacokinetic study with standard-dose nonfixed artesunate plus mefloquine.

Authors:  S Krudsood; S Looareesuwan; N Tangpukdee; P Wilairatana; W Phumratanaprapin; W Leowattana; K Chalermrut; S Ramanathan; V Navaratnam; P Olliaro; M Vaillant; J R Kiechel; W R J Taylor
Journal:  Antimicrob Agents Chemother       Date:  2010-06-14       Impact factor: 5.191

5.  Clinical experience with intravenous quinine, intramuscular artemether and intravenous artesunate for the treatment of severe malaria in Thailand.

Authors:  Srivicha Krudsood; Polrat Wilairatana; Suparp Vannaphan; Sombat Treeprasertsuk; Udomsak Silachamroon; Weerapong Phomrattanaprapin; Victor R Gourdeuk; Gary M Brittenham; Sornchai Looareesuwan
Journal:  Southeast Asian J Trop Med Public Health       Date:  2003-03       Impact factor: 0.267

6.  Comparative clinical trial of two-fixed combinations dihydroartemisinin-napthoquine-trimethoprim (DNP) and artemether-lumefantrine (Coartem/Riamet) in the treatment of acute uncomplicated falciparum malaria in Thailand.

Authors:  S Krudsood; K Chalermrut; C Pengruksa; S Srivilairit; U Silachamroon; S Treeprasertsuk; S Kano; G M Brittenham; S Looareesuwan
Journal:  Southeast Asian J Trop Med Public Health       Date:  2003-06       Impact factor: 0.267

7.  Comparison of two mefloquine regimens for treatment of Plasmodium falciparum malaria on the northeastern Thai-Cambodian border.

Authors:  F M Smithuis; J B van Woensel; E Nordlander; W S Vantha; F O ter Kuile
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

Review 8.  Antimalarial drug toxicity: a review.

Authors:  W Robert J Taylor; Nicholas J White
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

Review 9.  Artesunate. A review of its pharmacology and therapeutic efficacy in the treatment of malaria.

Authors:  L B Barradell; A Fitton
Journal:  Drugs       Date:  1995-10       Impact factor: 9.546

10.  Interventions to improve the use of antimalarials in south-east Asia: an overview.

Authors:  M Gomes; S Wayling; L Pang
Journal:  Bull World Health Organ       Date:  1998       Impact factor: 9.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.